SAM
ITCI

Senzar Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Senzar Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-144,624
Closed -$5.61M – 45
2016
Q2 		$5.61M Sell
144,624
-238,300
-62% -$8.56M 1.22% 26
2016
Q1 		$10.6M Buy
382,924
+30,000
+9% +$1,000K 2.11% 16
2015
Q4 		$19M Sell
352,924
-203,300
-37% -$10.3M 2.11% 15
2015
Q3 		$22.3M Buy
556,224
+394,924
+245% +$12.9M 3.24% 12
2015
Q2 		$5.15M Buy
161,300
+11,200
+7% +$284K 0.89% 32
2015
Q1 		$3.58M Buy
+150,100
New +$3.36M 0.87% 27

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Senzar Asset Management's ITCI Position: Q3 2016 in Review

Senzar Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2016, closing a stake of 144,624 shares — an estimated $5.61M sold.

Senzar Asset Management first reported a position in ITCI in Q1 2015 and held it in 6 quarters. The position peaked at $22.3M in Q3 2015. 132 funds tracked by Wall St. Rank hold ITCI as of Q3 2016.

  • Senzar Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2016 after selling out during the quarter.
  • Senzar Asset Management sold 144,624 Intra-Cellular Therapies Inc. shares in Q3 2016, an estimated $5.61M.
  • Senzar Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 6 quarters.
  • Senzar Asset Management's Intra-Cellular Therapies Inc. position peaked at $22.3M in Q3 2015.
  • 132 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2016.

Based on Senzar Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.